Literature DB >> 17129742

Multiple mechanisms of growth hormone-regulated gene transcription.

Teresa I Ceseña1, Tracy Xiao Cui, Graciela Piwien-Pilipuk, Julianne Kaplani, Anda-Alexandra Calinescu, Jeffrey S Huo, Jorge A Iñiguez-Lluhí, Roland Kwok, Jessica Schwartz.   

Abstract

Diverse physiological actions of growth hormone (GH) are mediated by changes in gene transcription. Transcription can be regulated at several levels, including post-translational modification of transcription factors, and formation of multiprotein complexes involving transcription factors, co-regulators and additional nuclear proteins; these serve as targets for regulation by hormones and signaling pathways. Evidence that GH regulates transcription at multiple levels is exemplified by analysis of the proto-oncogene c-fos. Among the GH-regulated transcription factors on c-fos, C/EBPbeta appears to be key, since depletion of C/EBPbeta by RNA interference blocks the stimulation of c-fos by GH. The phosphorylation state of C/EBPbeta and its ability to activate transcription are regulated by GH through MAPK and PI3K/Akt-mediated signaling cascades. The acetylation of C/EBPbeta also contributes to its ability to activate c-fos transcription. These and other post-translational modifications of C/EBPbeta appear to be integrated for regulation of transcription by GH. The formation of nuclear proteins into complexes associated with DNA-bound transcription factors is also regulated by GH. Both C/EBPbeta and the co-activator p300 are recruited to c-fos in response to GH, altering c-fos promoter activation. In addition, GH rapidly induces spatio-temporal re-localization of C/EBPbeta within the nucleus. Thus, GH-regulated gene transcription mediated by C/EBPbeta reflects the integration of diverse mechanisms including post-translational modifications, modulation of protein complexes associated with DNA and re-localization of gene regulatory proteins. Similar integration involving other transcription factors, including Stats, appears to be a feature of regulation by GH of other gene targets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17129742      PMCID: PMC1986646          DOI: 10.1016/j.ymgme.2006.10.006

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  75 in total

1.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy.

Authors:  Sam Holmstrom; Mary E Van Antwerp; Jorge A Iñiguez-Lluhi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

2.  Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts.

Authors:  Robert A Frost; Gerald J Nystrom; Charles H Lang
Journal:  Endocrinology       Date:  2002-02       Impact factor: 4.736

3.  SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.

Authors:  Toula Bouras; Maofu Fu; Anthony A Sauve; Fang Wang; Andrew A Quong; Neil D Perkins; Ronald T Hay; Wei Gu; Richard G Pestell
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

4.  Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone.

Authors:  G S Campbell; D J Meyer; R Raz; D E Levy; J Schwartz; C Carter-Su
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

5.  RhoA/ROCK activation by growth hormone abrogates p300/histone deacetylase 6 repression of Stat5-mediated transcription.

Authors:  Ling Ling; Peter E Lobie
Journal:  J Biol Chem       Date:  2004-04-20       Impact factor: 5.157

6.  Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites.

Authors:  P L Bergad; H M Shih; H C Towle; S J Schwarzenberg; S A Berry
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

7.  CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation.

Authors:  Krisztián A Kovács; Myriam Steinmann; Pierre J Magistretti; Olivier Halfon; Jean-René Cardinaux
Journal:  J Biol Chem       Date:  2003-07-11       Impact factor: 5.157

8.  Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-beta (C/EBP beta) and C/EBP delta.

Authors:  R W Clarkson; C M Chen; S Harrison; C Wells; G E Muscat; M J Waters
Journal:  Mol Endocrinol       Date:  1995-01

9.  Growth hormone stimulates c-fos gene expression by means of protein kinase C without increasing inositol lipid turnover.

Authors:  A Doglio; C Dani; P Grimaldi; G Ailhaud
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

10.  Acute nuclear actions of growth hormone (GH): cycloheximide inhibits inducible activator protein-1 activity, but does not block GH-regulated signal transducer and activator of transcription activation or gene expression.

Authors:  A M Gronowski; C Le Stunff; P Rotwein
Journal:  Endocrinology       Date:  1996-01       Impact factor: 4.736

View more
  27 in total

1.  Unbiased, genome-wide in vivo mapping of transcriptional regulatory elements reveals sex differences in chromatin structure associated with sex-specific liver gene expression.

Authors:  Guoyu Ling; Aarathi Sugathan; Tali Mazor; Ernest Fraenkel; David J Waxman
Journal:  Mol Cell Biol       Date:  2010-09-27       Impact factor: 4.272

Review 2.  Growth hormone in the tumor microenvironment.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Arch Endocrinol Metab       Date:  2019 Nov-Dec       Impact factor: 2.309

3.  Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.

Authors:  Elizabeth Drake Brooks; Dianne Little; Ramamani Arumugam; Baodong Sun; Sarah Curtis; Amanda Demaster; Michael Maranzano; Mark W Jackson; Priya Kishnani; Michael S Freemark; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

Review 4.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

5.  Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites.

Authors:  Satyanaryana Eleswarapu; Zhiliang Gu; Honglin Jiang
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

6.  Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription.

Authors:  Yili Chen; Grace Lin; Jeffrey S Huo; Deborah Barney; Zhenni Wang; Tamara Livshiz; David J States; Zhaohui S Qin; Jessica Schwartz
Journal:  Endocrinology       Date:  2009-04-30       Impact factor: 4.736

7.  Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.

Authors:  Grace Lin; Christopher R LaPensee; Zhaohui S Qin; Jessica Schwartz
Journal:  Mol Cell Endocrinol       Date:  2014-08-01       Impact factor: 4.102

8.  Gene expression in skeletal muscle after an acute intravenous GH bolus in human subjects: identification of a mechanism regulating ANGPTL4.

Authors:  Berthil F F Clasen; Thomas Krusenstjerna-Hafstrøm; Mikkel Holm Vendelbo; Kasper Thorsen; Carlos Escande; Niels Møller; Steen B Pedersen; Jens Otto L Jørgensen; Niels Jessen
Journal:  J Lipid Res       Date:  2013-04-20       Impact factor: 5.922

9.  JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells.

Authors:  Hui Jin; Nathan J Lanning; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2008-05-22

10.  Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages.

Authors:  Nicola M Heller; Xiulan Qi; Ilkka S Junttila; Kari Ann Shirey; Stefanie N Vogel; William E Paul; Achsah D Keegan
Journal:  Sci Signal       Date:  2008-12-23       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.